InsidersTradesSigma
Track the アステラス製薬株式会社 stock price and the full insider trade history of the company, a listed issuer based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). Market capitalisation: €3,786.3bn. The latest transaction was reported on 20 January 2026 (Holding update). Among the most active insiders: BlackRock Japan Co., Ltd.. Every trade is free.
Analysts rate アステラス製薬株式会社 Buy (bullish), based on 13 analysts. Average price target: JP¥2,385.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Astellas Pharma Inc. is a Japanese pharmaceutical company focused on the research and development of innovative medicines. It primarily concentrates on oncology, urology, and infectious diseases.